Ingrid Wilson

Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-life.

D. Mckerrecher, C. Johnstone, Craig S Donald, 2011, Bioorganic & medicinal chemistry letters.

Property based optimisation of glucokinase activators – discovery of the phase IIb clinical candidate AZD1656

Michael J. Waring, Graeme R. Robb, David S. Clarke, 2012 .